Please note that any information that you supply is protected by our Privacy Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
|
A new study has confirmed the efficacy of Mirtoselect® in patient affected by diabetic retinopathy. This testimony has reinforced its already attested action, in prevention of loss of harpness, improvement of visual contrast and onset of macular oedema.